Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer

Figure 3

OPLS-DA score plot of lipid profile of early-stage NSCLC, LBD, and HC after unit variance (uv) scaling ((a) NSCLC versus HC; (b) NSCLC versus LBD; (c) LBD versus HC). NSCLC, non-small cell lung cancer; LBD, lung benign disease; HC, healthy controls.

(a)

(b)

(c)